Does dehydroepiandrosterone influence the expression of urticaria?-a mini review

Inflammation

Volumn 34, Issue 5, 2011, Pages 362-366

  Kasperska Zajac, A ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Chronic urticaria; Dehydroepiandrosterone; Inflammation; Stress

Indexed keywords

CYTOKINE; HYDROCORTISONE; INTERLEUKIN 6; PRASTERONE SULFATE; PROLACTIN; STEROID;

CHRONIC URTICARIA; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; IMMUNE DYSREGULATION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SKIN TEST;

CHRONIC DISEASE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; INTERLEUKIN-6; MALE; NEUROIMMUNOMODULATION; URTICARIA;

EID: 80655139872     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9242-z     Document Type: Review

References (52)

1. Zuberbier, T., R. Asero, C. Bindslev-Jensen, G. Walter Canonica, M.K. Church, A. Giménez-Arnau, C.E. Grattan, A. Kapp, H.F. Merk, B. Rogala, S. Saini, M. Sánchez-Borges, P. Schmid-Grendelmeier, H. Schünemann, P. Staubach, GA. Vena, B. Wedi, and M. Maurer. 2009. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classifica-tion and diagnosis of urticaria Allergy 64: 1417-1426.
2. Greaves, M.W. 1995. Chronic urticaria. The New England Journal of Medicine 332: 1767-1772.
3. Caproni, M., B. Giomi, W. Volpi, L. Melani, E. Schincaglia, D. Macchia, M. Manfredi, A. DAgata, and P. Fabbri. 2005. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autolo-gous serum-inducedwheals. Clinical Immunology 114: 284-292. (Pubitemid 40255133)
4. Piconi, S., D. Trabattoni, E. Iemoli, M.L. Fusi, M.L. Villa, F. Milazzo, and M. Clerici. 2002. Immune profiles of patients with chronic idiopathic urticaria. International Archives of Allergy and Immunology 128: 59-66. (Pubitemid 34621667)
5. Angioni, S., F. Petraglia, and A.R. Genezzani. 1991. Immune-endocrine correlations: a new aspect in human physiology. Acta Europaea Fertilitatis 22: 167-170.
6. Bertinotti, L., I. Miniati, and M.M. Cerinic. 2002. Angioedema and systemic sclerosis. A review of the literature. Scandinavian Journal of Rheumatology 31: 178-180. (Pubitemid 34713084)
7. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2008. Sex hormones and urticaria. Journal of Dermatological Science 52: 79-86.
8. Loria, R.M., and DA. Padgett. 1992. Mobilization of cutaneous immunity for systemic protection against infections. Annals of the New York Academy of Sciences 650: 363-366.
9. Kimonides, V.G., N.H. Khatibi, C.N. Svendsen, M.V. Sofroniew, and J. Herbert. 1998. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 95: 1852-1857. (Pubitemid 28103483)
10. Goodyer, I.M., J. Herbert, P.M.E. Altham, J. Pearson, S.M. Secher, and H.M. Shiers. 1996. Adrenal secretion during major depression in 8 to 16 year olds, I: altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psycholog-ical Medicine 26: 245-256. (Pubitemid 26075198)
11. Wolkowitz, O.M., V.I. Reus, E. Roberts, F. Manfredi, T. Chan, W.J. Raum, S. Ormiston, R. Johnson, J. Canick, L. Brizendine, and H. Weingartner. 1997. Dehydroepiandrosterone (DHEA) treatment of depression. Biological Psychiatry 41: 311-318. (Pubitemid 27095256)
12. Micheal, A., A. Jenaway, E.S. Paykel, and J. Herbert. 2000. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biological Psychiatry 48: 989-995.
13. Fava, M., J.F. Rosenbaum, RA. Mac Laughlin, G.E. Tesar, M.H. Pollack, L.S. Cohen, and M. Hirsch. 1989. Dehydroepiandroster-one-sulfate/cortisol ratio in panic disorder. Psychiatry Research 28: 345-350.
14. Kroboth, P.D., F.S. Salek, A.L. Pittenger, T.J. Fabian, and R.F. Frye. 1999. DHEA and DHEA-S: a review. Journal of Clinical Pharmacology 39: 327-348. (Pubitemid 29159823)
15. Dillon, J.S. 2005. Dehydroepiandrosterone, dehydroepiandroster-one sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Current Drug Targets. Inflammation and Allergy 4: 377-385. (Pubitemid 40873125)
16. Tagawa, N., J. Tamanaka, A. Fujinami, Y. Kobayashi, T. Takano, S. Fukata, K. Kuma, H. Tada, and N. Amino. 2000. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pre-gnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clinical Chemistry 46: 523-528. (Pubitemid 30210723)
17. Barry, N.N., J.L. Mc Guire, and R.F. van Vollenhoven. 1998. Dehydroepiandrosterone in systemic lupus erythematosus: relation-ship between dosage, serum levels, and clinical response. The Journal of Rheumatology 25: 2352-2356. (Pubitemid 28551851)
18. Kasperska-Zajac, A. 2010. Asthma and dehydroepiandrosterone (DHEA): facts and hypotheses. Inflammation. doi:10.1007/s10753-010-9188-1.
19. Morgan 3rd, C.A., S. Southwick, G. Hazlett, A. Rasmusson, G. Hoyt, Z. Zimolo, and D. Charney. 2004. Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress. Archives of General Psychiatry 61: 819-825. (Pubitemid 39031121)
20. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2006. Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria. Journal of Dermatolog-ical Science 41: 80-81. (Pubitemid 43075435)
21. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2006. Lower serum concentration of dehydyroepiandrosterone sulphate in patients with chronic idiopathic urticaria. Allergy 61: 1489-1490. (Pubitemid 44665320)
22. Brzoza, Z., A. Kasperska-Zajac, and B. Rogala. 2007. Serum prolactin concentration and its relationship with dehydroepiandros-terone sulfate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test. Allergy 62: 566-567. (Pubitemid 46608354)
23. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2007. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine 39: 142-146. (Pubitemid 47520707)
24. Brzoza, Z., A Kasperska-Zajac, K. Badura-Brzoza, J. Matysiakiewicz, R.T. Hese, and B. Rogala. 2008. Decline in dehydroepiandrosterone sulphate observed in chronic urticaria is associated with psycho-logical distress. Psychosomatic Medicine 70: 723-728.
25. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2008. Lower serum dehydroepiandrosterone sulfate (DHEA-S) concentration in chronic idiopathic urticaria: a secondary transient phenomenon? The British Journal of Dermatology 159: 743-744
26. Kasperska-Zaja̧c, A., Z. Brzoza, and B. Rogala. 2007. Circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in women suffering from chronic idiopathic urticaria in relation to their pre- or post-menopausal status. Maturitas 58: 211-215. (Pubitemid 350086830)
27. Kaplan, A.P., and M. Greaves. 2009. Pathogenesis of chronic urticaria. Clinicaland Experimental Allergy39: 777-87.
28. Straub, R.H., A. Schuld, J. Mullington, M. Haack, J. Schölmerich, and T. Pollmacher. 2002. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. The Journal of Endocrinology 175: 467-474. (Pubitemid 35414393)
29. Schwartz, K.E. 2002. Autoimmunity, dehydroepiandrosterone (DHEA), and stress. The Journal of Adolescent Health 30S: 37-43. (Pubitemid 34275451)
30. Glasow, A., M. Breidert, A. Haidan, U. Anderegg, PA. Kelly, and S.R. Bornstein. 1996. Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. The Journal of Clinical Endocrinology and Metabolism 81: 3103-3111. (Pubitemid 26323916)
31. Simard, J., A. Vincent, R. Duchesne, and F. Labrie. 1988. Full oestrogenic activity of C19-delta 5 adrenal steroids in rat pituitary lactotrophs and somatotrophs. Molecular and Cellular Endocrinol-ogy 55: 233-242. (Pubitemid 18055213)
32. Straub, R.H., L. Konecna, S. Hrach, G. Rothe, M. Kreutz, J. Scholmerich, W. Falk, and B. Lang. 1998. Serum dehydroepian-drosterone (DHEA) and DHEAS sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. The Journal of Clinical Endocrinologyand Metabolism 83: 2012-2017. (Pubitemid 28496330)
33. Path, G., S.R. Bornstein, M. Ehrhart-Bornstein, and WA. Scherbaum. 1997. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroido-genesis. The Journal of Clinical Endocrinology and Metabolism 82: 2343-2349. (Pubitemid 27287610)
34. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340: 448-454. (Pubitemid 29084777)
35. Lutgendorf, S.K., L. Garand, K.C. Buckwalter, T.T. Reimer, S.Y Hong, and D.M. Lubaroff. 1999. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. Journal of Gerontology 54: 343-439.
36. Panconesi, E., and G. Hautmann. 1995. Stress, stigmatization and psychosomatic purpuras. International Angiology 14: 130-137.
37. Baum, A. 1990. Stress, intrusive imagery, and chronic distress. Health Psychology 9: 653-675.
38. Arck, P., and R. Paus. 2006. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuro-immunomodulation 13: 347-356. (Pubitemid 47289518)
39. Berrino, A.M., S. Voltolini, D. Fiaschi, S. Pellegrini, D. Bignardi, P. Minale, C. Troise, and E. Maura. 2006. Chronic urticaria: importance of a medical-psychological approach. Allergy and Immunology (Paris) 38: 149-152. (Pubitemid 43937896)
40. Yang, H.Y., C.C. Sun, Y.C. Wu, and J.D. Wang. 2005. Stress, insomnia, and chronic idiopathic urticaria-a case-control study. Journal of the Formosan Medical Association 104: 254-263.
41. Papadopoulou, N., D. Kalogeromitros, N.G. Staurianeas, D. Tiblalexi, and T.C. Theoharides. 2005. Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. Journal of Investigative Dermatology 125: 952-995.
42. Fava, G.A., G.I. Perini, P. Santonastaso, and C.V. Fornasa. 1980. Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. The British Journal of Medical Psychology 53: 277-282. (Pubitemid 11244772)
43. Katelaris, C.H., and J.E. Peake. 2006. 5. Allergy and the skin: eczema and chronic urticaria. The Medical Journal of Australia 185: 517-522. (Pubitemid 44756216)
44. Kumar, S.A., and B.L. Martin. 1999. Urticaria and angioedema: diagnostic and treatment considerations. The Journal of the American Osteopathic Association 99(3 Suppl): S1-4.
45. Baiardini, I., A. Giardini, M. Pasquali, P. Dignetti, L. Guerra, C. Specchia, F. Braido, G. Majani, and G.W. Canonica. 2003. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 58: 621-3. (Pubitemid 36831317)
46. Mizota, K., A. Yoshida, H. Uchida, R. Fujita, and H. Ueda. 2005. Novel type of Gq/11 protein-coupled neurosteroid receptor sensitive to endocrine disrupting chemicals in mast cell line (RBL-2H3). British Journal of Pharmacology 145: 545-550. (Pubitemid 40966284)
47. Hidvegi, T., G.K. Feher, T. Feher, E. Koo, and G. Fust. 1984. Inhibition of the complement activation by an adrenal androgen, dehydroepiandrosterone. Complement 1: 201-206.
48. Powell, J.M., and G. Sonnenfeld. 2006. The effects of dehydroe-piandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production. Journal of Interferon & Cytokine Research 26: 34-39. (Pubitemid 43201735)
49. Mc Lachlan, J.A., C.D. Serkin, and O. Bakouche. 1996. Dehy-droepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. Journal of Immunology 156: 328-335. (Pubitemid 26006980)
50. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2008. Dehydroe- piandrosterone and dehydroepiandrosterone sulphate in atopic allergy and chronic urticaria. Inflammation 31: 141-145.
51. Murakami, K., T. Nakagawa, G. Yamashiro, K. Araki, and K. Akasofu. 1993. Adrenal steroids in serum during danazol therapy, taking into account cross-reactions between danazol metabolites and serum androgens. Endocrine Journal 40: 659-664. (Pubitemid 24085031)
52. Ceuppens, J.L., E. Stevens, and M. Rijon. 1985. Danazol treatment in chronic urticaria and delayed pressure urticaria: effect on protease inhibitors. Allergie und Immunologie 17: 46-51. (Pubitemid 15137495)